Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Fraga Silva, Thais F C ^a   Mimura, Luiza A N ^a   Marchetti, Camila M ^a   Chiuso Minicucci, Fernanda ^a   Francą, Thais G D ^a   Zorzella Pezavento, Sofia F G ^a   Venturini, James ^a   Arruda, Maria S P ^a   Sartori, Alexandrina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENCEPHALITOGENIC PROTEIN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; IL17A PROTEIN, MOUSE; PEPTIDE FRAGMENT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FUNGAL COLONIZATION; FUNGUS HYPHAE; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; SPLEEN; WEIGHT REDUCTION; YEAST; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929347060     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/635052     Document Type: Article

References (40)

1. R. Hohlfeld, "Multiple sclerosis: human model for EAE?" European Journal of Immunology, vol. 39, no. 8, pp. 2036-2039, 2009.
2. Multiple Sclerosis International Federation-MSIF, The Atlas of Multiple Sclerosis 2013, Multiple Sclerosis International Federation, London, UK, 2013.
3. E. Lavi and C. S. Constantinescu, Experimental Models of Multiple Sclerosis, Springer, New York, NY, USA, 2005.
4. M. Sospedra andR. Martin, "Immunology ofmultiple sclerosis, " Annual Review of Immunology, vol. 23, pp. 683-747, 2005.
5. A. G. Baxter, "The origin and application of experimental autoimmune encephalomyelitis, " Nature Reviews Immunology, vol. 7, no. 11, pp. 904-912, 2007.
6. C. Cassan and R. S. Liblau, "Immune tolerance and control of CNS autoimmunity: from animal models to MS patients, " Journal of Neurochemistry, vol. 100, no. 4, pp. 883-892, 2007.
7. H. Neumann, "Molecular mechanisms of axonal damage in inflammatory central nervous system diseases, " Current Opinion in Neurology, vol. 16, no. 3, pp. 267-273, 2003.
8. N. M. Rebenko-Moll, L. Liu, A. Cardona, and R. M. Ransohoff, "Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details, " Current Opinion in Immunology, vol. 18, no. 6, pp. 683-689, 2006.
9. M. Rodriguez, "Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis, " Brain Pathology, vol. 17, no. 2, pp. 219-229, 2007.
10. J. R. Oksenberg, "Decoding multiple sclerosis: an update on genomics and future directions, " Expert Review of Neurotherapeutics, vol. 13, no. 12, pp. 11-19, 2013.
11. A. Venkatesan and R. T. Johnson, "Infections and multiple sclerosis, " Handbook of Clinical Neurology, vol. 122, pp. 151-171, 2014.
12. J. M. K. Murthy and C. Sundaram, "Fungal infections of the central nervous system, " Handbook of Clinical Neurology, vol. 121, pp. 1383-1401, 2014.
13. S. K. Fridkin and W. R. Jarvis, "Epidemiology of nosocomial fungal infections, " Clinical Microbiology Reviews, vol. 9, no. 4, pp. 499-511, 1996.
14. F. L. van de Veerdonk, M. G. Netea, L. A. Joosten, J. W. M. van der Meer, and B. J. Kullberg, "Novel strategies for the preventionand treatment of Candida infections: the potential of immunotherapy, " FEMSMicrobiology Reviews, vol. 34, no. 6, pp. 1063-1075, 2010.
15. H. Wisplinghoff, T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond, "Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study, " Clinical Infectious Diseases, vol. 39, p. 309, 2004.
16. J. Benito-León, D. Pisa, R. Alonso, P. Calleja, M. Dáz-Sánchez, and L. Carrasco, "Association between multiple sclerosis and Candida species: evidence froma case-control study, " European Journal of Clinical Microbiology & Infectious Diseases, vol. 29, no. 9, pp. 1139-1145, 2010.
17. D. Pisa, R. Alonso, F. J. Jiménez-Jiménez, and L. Carrasco, "Fungal infection in cerebrospinal fluid fromsomepatients with multiple sclerosis, " European Journal of Clinical Microbiology and Infectious Diseases, vol. 32, no. 6, pp. 795-801, 2013.
18. A. Vojdani, P. Rahimian, H. Kalhor, and E. Mordechai, "Immunological cross reactivity between Candida albicans and human tissue, " Journal of clinical & laboratory immunology, vol. 48, no. 1, pp. 1-15, 1996.
19. C. B. Purzycki and D. H. Shain, "Fungal toxins and multiple sclerosis: a compelling connection, " Brain Research Bulletin, vol. 82, no. 1-2, pp. 4-6, 2010.
20. M. S. Lionakis, J. K. Lim, C.-C. R. Lee, and P. M. Murphy, "Organ-specific innate immune responses in a mouse model of invasive candidiasis, " Journal of Innate Immunity, vol. 3, no. 2, pp. 180-199, 2011.
21. P. A. Davis and P. T. Rudd, Neonatal Meningitis, McKeith Press, London, UK, 1994.
22. O. H. Del Brutto, "Central nervous mycotic infections, " Revue Neurologique, vol. 30, pp. 447-459, 2000.
23. J. Sánchez-Portocarrero, E. Pérez-Cecilia, O. Corral, J. Romero-Vivas, and J. J. Picazo, "The centralnervous systemandinfection by Candida species, " Diagnostic Microbiology and Infectious Disease, vol. 37, no. 3, pp. 169-179, 2000.
24. A. Borha, J.-J. Parienti, E. Emery, O. Coskun, S. Khouri, and J.-M. Derlon, "Candida Albicans cerebral granuloma in an immunocompetent patient. A case report, " Neurochirurgie, vol. 55, no. 1, pp. 57-62, 2009.
25. A. Ben-Nun, N. Kaushansky, N. Kawakami et al. , "From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development, " Journal of Autoimmunity, vol. 54, pp. 33-50, 2014.
26. C. C. A. Bernard, T. G. Johns, A. Slavin et al. , "Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis, " Journal of Molecular Medicine, vol. 75, no. 2, pp. 77-88, 1997.
27. D. H. M. L. P. Navarathna, J. Munasinghe, M. J. Lizak, D. Nayak, D. B. Mcgavern, and D. D. Roberts, "MRI confirms loss of blood-brain barrier integrity in a mousemodel of disseminated candidiasis, " NMR in Biomedicine, vol. 26, no. 9, pp. 1125-1134, 2013.
28. T. F. C. Fraga-Silva, J. Venturini, and M. S. P. de Arruda, "Trafficking of phagocytic peritoneal cells in hypoinsulinemichyperglycemic mice with systemic candidiasis, " BMC Infectious Diseases, vol. 13, article 147, 2013.
29. W. E. F. Klinkert, K. Kojima, W. Lesslauer, W. Rinner, H. Lassmann, andH. Wekerle, "TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview, " Journal of Neuroimmunology, vol. 72, no. 2, pp. 163-168, 1997.
30. C. Lock, G. Hermans, R. Pedotti et al. , "Gene-microarray analysis ofmultiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, " Nature Medicine, vol. 8, no. 5, pp. 500-508, 2002.
31. J. M. Fletcher, S. J. Lalor, C. M. Sweeney, N. Tubridy, and K. H. G. Mills, "T cells in multiple sclerosis and experimental autoimmune encephalomyelitis, " Clinical and Experimental Immunology, vol. 162, no. 1, pp. 1-11, 2010.
32. D. W. Luchtman, E. Ellwardt, C. Larochelle, and F. Zipp, "IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: current and future developments, " Cytokine&Growth Factor Reviews, vol. 25, no. 4, pp. 403-413, 2014.
33. D. Pisa, R. Alonso, and L. Carrasco, "Fungal infection in a patient with multiple sclerosis, " European Journal of Clinical Microbiology and Infectious Diseases, vol. 30, no. 10, pp. 1173-1180, 2011.
34. P. Bonifazi, T. Zelante, C. D'Angelo et al. , "Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans, " Mucosal Immunology, vol. 2, no. 4, pp. 362-374, 2009.
35. N. Whibley, D. M. Maccallum, M. A. Vickers et al. , "Expansion of Foxp3+ T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge, " European Journal of Immunology, vol. 44, no. 4, pp. 1069-1083, 2014.
36. A. P. Kohm, P. A. Carpentier, H. A. Anger, and S. D. Miller, "Cutting edge: CD4+CD25+ regulatory T cells suppress antigenspecific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis, " The Journal of Immunology, vol. 169, no. 9, pp. 4712-4716, 2002.
37. S. F. G. Zorzella-Pezavento, F. Chiuso-Minicucci, T. G. D. Francą et al. , "Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 production, " Mediators of Inflammation, vol. 2013, Article ID 519627, 10 pages, 2013.
38. A. S. Farias, R. L. Talaisys, Y. C. Blanco et al. , "Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis, " PLoS ONE, vol. 6, no. 3, Article ID e17849, 2011.
39. W. A. Banks, A. J. Kastin, and R. D. Broadwell, "Passage of cytokines across the blood-brain barrier, " Neuroimmunomodulation, vol. 2, no. 4, pp. 241-248, 1995.
40. W. A. Banks, "Blood-brain barrier transport of cytokines: a mechanism for neuropathology, " Current Pharmaceutical Design, vol. 11, no. 8, pp. 973-984, 2005.